Pfizer looks past sterile injectable worries with strong quarter by Kyle Blankenship Thursday, April 30, 2020 Pfizer saw double-digit growth in its sterile injectables portfolio after a yearslong effort to bring that business up to regulator muster.
Longtime Abbott chief Miles White to step down as CEO by Angus Liu Wednesday, November 13, 2019 Abbott helmsman Miles White, who oversaw the spinoffs of AbbVie and Hospira, will step down as CEO after 21 years at the top job.
Manufacturing News of Note: Catalent, Hospira, Novartis, Sagent Tuesday, September 10, 2019 Catalent has invested $9 million in a clinical supply facility and Sagent has access to expanded manufacturing in Canada.
Fresenius limits heparin as shortages of blood thinner persist by Joseph Keenan Monday, September 2, 2019 Swine fever in China has forced one of the largest manufacturers of heparin to begin limiting allocations of the treatment.
Mylan and Hospira recall drugs after particulate discovered by Eric Palmer Tuesday, March 19, 2019 Mylan is recalling a chemo drug and Hospira a commonly used solution because potentially dangerous particulate has been discovered in vials.
FDA issues warning letter to India plant Pfizer is closing by Eric Palmer Wednesday, March 13, 2019 Pfizer is closing a Hospira plant in India, but the FDA still issued a warning letter for a list of serious violations it uncovered last year.
Pfizer offers ‘attractive’ severance package to Indian employees by Angus Liu Monday, January 14, 2019 Pfizer is offering some 1,700 door-heading employees "an attractive financial scheme that is significantly higher than the legal requirements."
Pfizer to cut 2 Hospira plants, 1,700 jobs in India by Angus Liu Wednesday, January 9, 2019 Pfizer's plan to close two legacy Hospira plants in India puts 1,700 jobs stationed there at risk.
Pfizer again supplying pain drugs to veterinarians by Eric Palmer Monday, December 17, 2018 The FDA’s Center for Veterinary Medicine has reached an agreement for Pfizer to divert part of a new source of injected pain drugs to veterinarians.
Issues persist at Pfizer's Hospira injectables plant by Eric Palmer Wednesday, December 12, 2018 The most recent inspection of Pfizer's troubled injectables plant in McPherson, Kansas, found eight observations, seven of them repeats.
